Tags: Drug.

Ranolazine sold under the trade name Ranexa by Gilead Sciences (who acquired the developer CV Therapeutics in 2009) is an antianginal medication. On January 31 2006 ranolazine was approved for use in the United States by the Food and Drug Administration (FDA) for the treatment of chronic angina pectoris.

Ranolazine.svg
ATC prefix
C01
ATC suffix
EB18
Bioavailability
35.0
CAS number
142387-99-3
DrugBank
DB00243
FDA UNII code
A6IEZ5M406
IUPAC name
(RS)-N-(26-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)-propyl]piperazin-1-yl]acetamide
PubChem
56959

Loading...

This page contains content from the copyrighted Wikipedia article "Ranolazine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.